Botulinum toxin in the treatment of tardive dystonia

J Clin Psychopharmacol. 1997 Dec;17(6):497-8. doi: 10.1097/00004714-199712000-00016.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / therapeutic use*
  • Dopamine Antagonists / adverse effects
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Agents / therapeutic use*
  • Retrospective Studies

Substances

  • Dopamine Antagonists
  • Neuromuscular Agents
  • Botulinum Toxins, Type A